Valleywise Health Medical Center

Phoenix, Arizona 85008

4 studies enrolling now · 19 studies all time

What they study most

Acute Coronary Syndrome, Acute Respiratory Distress Syndrome, Atrial Fibrillation, Breast Cancer, Burns, COVID-19, COVID-19 Pneumonia, Cardiovascular Diseases, Cardiovascular Risk Factor, Colon Cancer, Covid19, Healthy

Studies at this site

• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies — Recruiting now
• Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns — Recruiting now
• Adaptive Symptom Self-Management Immunotherapy Study — Running, not enrolling
• Safety Study of Microlyte DualGuard — Starting soon
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors — Stopped early
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• NATIENS: Optimal Management and Mechanisms of SJS/TEN — Completed
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 — Completed
• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis — Completed
• A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. — Completed
• The OPBC-07/microNAC Study — Running, not enrolling
• Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study — Completed
• Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries — APPROVED_FOR_MARKETING
• Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 — Stopped early
• A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia — Completed
• Convalescent Plasma in Outpatients With COVID-19 — Completed